Journal of Artificial Organs

, Volume 21, Issue 2, pp 261–264 | Cite as

A case report of the first application of culture epithelial autograft (JACE®) for giant congenital melanocytic nevus after its approval in Japan

  • Naoki Morimoto
  • Natsuko Kakudo
  • Ayako Kako
  • Keiko Nishimura
  • Toshihito Mitsui
  • Ryohei Miyake
  • Atsuyuki Kuro
  • Masakatsu Hihara
  • Kenji Kusumoto
Case Report Artificial Skin, Muscle, Bone / Joint, Neuron
  • 109 Downloads

Abstract

In Japan, the JACE® cultured epidermal autograft (CEA) was approved and covered by public healthcare insurance for use in the treatment of giant congenital melanocytic nevus (GCMN) in 2016. We herein report the results of the application of JACE® after curettage and Q-switched ruby laser therapy. The current patient was the first patient with GCMN to be treated with JACE® since its approval. A 3-month-old girl had a hairy GCMN of 9.5 cm in diameter from her cheek to her temple on the left side of her face. We first performed curettage of the nevus on the temple and applied irradiation using a Q-switched ruby laser; however, erosion relapsed at 2 months after first surgery. After preparing JACE®, we performed curettage a second time at 7 months with irradiation of a Q-switched ruby laser and the application of the CEA. The CEA took successfully and the wound was completely epithelized at 1 week after grafting. Re-pigmentation is an important issue that remains to be solved; however, overcoming this would allow for a deeper abrasion or more intense laser irradiation to be performed in cases in which CEA will be subsequently applied.

Keywords

Giant congenital melanocytic nevus Curettage Q-switched ruby laser therapy Cultured epithelial autograft 

References

  1. 1.
    Whang KK, Kim MJ, Song WK, Cho S. Comparative treatment of giant congenital melanocytic nevi with curettage or Er:YAG laser ablation alone versus with cultured epithelial autografts. Dermatol Surg. 2005;31(12):1660–7.PubMedGoogle Scholar
  2. 2.
    Viana AC, Gontijo B, Bittencourt FV. Giant congenital melanocytic nevus. AnBras Dermatol. 2013;88(6):863–78.Google Scholar
  3. 3.
    Arad E, Zuker RM. The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications. Plast Reconstr Surg. 2014;133(2):367–76.CrossRefPubMedGoogle Scholar
  4. 4.
    Matsumura H, Matsushima A, Ueyama M, Kumagai N. Application of the cultured epidermal autograft “JACE(®”) for treatment of severe burns: results of a 6-year multicenter surveillance in Japan. Burns. 2016;42(4):769–76.CrossRefPubMedGoogle Scholar
  5. 5.
    Kishi K, Okabe K, Ninomiya R, Konno E, Hattori N, Katsube K, Imanish N, Nakajima H, Nakajima T. Early serial Q-switched ruby laser therapy for medium-sized to giant congenital melanocytic naevi. Br J Dermatol. 2009;161(2):345–52.CrossRefPubMedGoogle Scholar
  6. 6.
    Rasmussen BS, Henriksen TF, Kølle SF, Schmidt G. Giant congenital melanocytic nevus: report from 30 years of experience in a single department. Ann Plast Surg. 2015;74(2):223–9.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 2017

Authors and Affiliations

  1. 1.Department of Plastic and Reconstructive SurgeryKansai Medical UniversityHirakataJapan

Personalised recommendations